Statistics
Publications
52
Citations
18K
H-Index
41
Active since
1996
Markus Warmuth is an author at Genomics Institute of the Novartis Research Foundation specializing in oncology, molecular oncology, and medicine.
Publications per year
1996–2025
52
52
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Jordi Barretina, Giordano Caponigro, Nicolas Stransky et al. · Nature · 2012 · 8.5K citations
Medicine, Oncology, Pharmacology +15
Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases
Ying-Nan P. Chen, Matthew J. LaMarche, Ho Man Chan et al. · Nature · 2016 · 929 citations
Targeting Bcr–Abl by combining allosteric with ATP-binding-site inhibitors
Jianming Zhang, Francisco Adrián, Wolfgang Jahnke et al. · Nature · 2010 · 599 citations
The allosteric inhibitor ABL001 enables dual targeting of BCR–ABL1
Andrew A. Wylie, Joseph Schoepfer, Wolfgang Jahnke et al. · Nature · 2017 · 596 citations
1–5 of 52